Product description
ARTERINORM capsules is a new formula in line with new EU-regulations, effective against hypercholesteremia with efficacy proven in a clinical trial
 
Indications
 
• Primary hypercholesterolemia IIa and IIb type
• Combined hypercholesterolemia and hypertriglyceridemia, hyperproteinemia reluctant to correction with special diet and exercise
• Diabetes
• Ischemic heart disease
• myocardial infarction preventive measures
• Reducing the risk of death
• Slowing the progression of atherosclerosis
• Reduced risk of revasculation procedures
• Cerebrovascular disease
 
 
Unique selling points (USP’s)
Triple Strike at hypercholesterolemia:
Decreases the synthesis of cholesterol LDL* (the most atherogenic fraction of cholesterol), triglycerides and increases HDL levels* (anti-atherogenic lipoproteins)
Lowers blood homocysteine
Has an anti-oxidant effect
 
formula is in line with latest EU-regulations
efficacy is proven in a clinical several trials with in total more than 1500 patients